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AutophagyCardiac metabolic stress is a hallmark of many cardiac pathologies, including diabetes. Cardiac glycogen mis-
handling is a frequentmanifestation of various cardiopathologies. Diabetic females have a higher risk of heart dis-
ease thanmales, yet sex disparities in cardiacmetabolic stress settings are notwell understood. Oestrogen acts on
key glycogen regulatory proteins. The goal of this study was to evaluate sex-speciﬁc metabolic stress-triggered
cardiac glycogen handling responses.Male and female adult C57Bl/6Jmicewere fasted for 48 h. Cardiac glycogen
content, particle size, regulatory enzymes, signalling intermediates and autophagic processeswere evaluated. Fe-
male hearts exhibited 51% lower basal glycogen content thanmales associatedwith lower AMP-activated-kinase
(AMPK) activity (35% decrease in pAMPK:AMPK). With fasting, glycogen accumulated in female hearts linked
with decreased particle size and upregulation of Akt and AMPK signalling, activation of glycogen synthase and
inactivation of glycogen phosphorylase. Fasting did not alter glycogen content or regulatory proteins in male
hearts. Expression of glycogen autophagy marker, starch-binding-protein-domain-1 (STBD1), was 63% lower
in female hearts than males and increased by 69% with fasting in females only. Macro-autophagy markers, p62
and LC3BII:I ratio, increased with fasting in male and female hearts. This study identiﬁes glycogen autophagy
(‘glycophagy’) as a potentially important component of the response to cardiac metabolic stress. Glycogen au-
tophagy occurs in association with a marked and selective accumulation of glycogen in the female myocardium.
Our ﬁndings suggest that sex-speciﬁc differences in glycogen handlingmay have cardiopathologic consequences
in various settings, including diabetic cardiomyopathy.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Metabolic stress plays an important role in diabetic cardiac patholo-
gy, characterised by a disturbance in the glucose-insulin balance [1]. The
Framingham heart study reported a 5-fold increase in heart failure risk
in diabetic females compared to a 2-fold increase inmaleswith diabetes
[2], suggesting thatwomen exhibit a heightened vulnerability to diabet-
ic heart disease. The mechanisms of sex-dependent metabolic stress-
related cardiac pathology have not been elucidated. Experimentally,
oestrogen is known to modulate the insulin signalling pathway via
upregulation of Akt in cardiomyocytes [3]. This pathway plays a crucial
role in themetabolic stress response via regulation of glucose transport
and storage as glycogen; sex-speciﬁc modulation of these processes has
not been investigated.gy, University of Melbourne,
fax: +61 3 83445818.
e).
ty of Auckland, Auckland, New
. Open access under CC BY-NC-ND liceGlycogen is a large intracellular particle consisting of thousands of
glucosemoieties, and glycogenmishandling is a key feature of metabol-
ic stress. For over 80 years it has been known that glycogen deposition
is increased in the humanmyocardium under pathologic circumstances
associatedwith diabetic cardiomyopathy [4]. The basis for this is still not
understood, but this is a replicated ﬁnding in a number of diabetic ex-
perimental models [5–7]. This occurrence of glycogen accumulation
when glucose supply is restricted through impaired tissue uptake
would appear to be a paradoxical metabolic stress response. In an ex-
perimental setting of acute metabolic stress induced by fasting, cardiac
glycogen accumulation is also observed. Rodent studies have shown
that the cardiac glycogen content increases in parallel with depletion
of liver and skeletal muscle glycogen stores [8]. Glycogen-handling re-
sponses to an acute metabolic challenge are clearly tissue-speciﬁc. Un-
derstanding these metabolic processes of glycogen handling in
metabolically stressed cardiac tissue may provide insight into the para-
doxical accumulation of glycogen in the diabetic heart.
Glycogen storage diseases are characterised by an accumulation of
glycogen-ﬁlled autophagosomes in themyocardium [9], demonstrating
a close association of glycogen and autophagy. A distinct ‘glycogen au-
tophagy’ process has been observed in neonatal hearts where
membrane-bound vacuoles containing glycogen particles are abundant
on electron microscopy images [10]. Thus autophagic degradation ofnse.
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regulated homeostatic degradation pathway catalysed by glycogen
phosphorylase. The basis for shunting glycogen through autophagic
degradation has not been established but it is speculated that this
pathway is selective for glycogen particles with aberrant branching or
abnormal structure that limits the accessibility of phosphorylase target
sites [11].
Starch-binding domain-containing protein 1 (STBD1) is involved in
binding glycogen and mediating membrane anchorage via interaction
with the cognate autophagy protein GABA(A) receptor-associated pro-
tein like 1 (GABARAPL1). It is therefore evident that a speciﬁc autophagy
pathway exists for degradation of glycogen, termed ‘glycophagy’
[12,13]. This terminology distinguishes glycogen targeted autophagic
processes from the more well characterised protein degradation path-
ways, described generally as ‘macrophagy’. It is not known whether
the glycogen autophagy pathway is operational in the heart. Interest-
ingly GABARAPL1 is an oestrogen-regulated gene [14] with the poten-
tial to mediate sex speciﬁcity of glycogen handling and autophagy, but
to date, this mechanism has not been investigated.
Glycogen handling and autophagy share similar regulatory path-
ways. The insulin signalling (‘cell survival’) pathway promotes glycogen
storage via Akt inhibition of glycogen synthase kinase 3β (GSK3β) and
suppresses autophagy via mammalian target of rapamycin (mTOR)
inhibition of unc51-like kinase 1/2 (ULK1/2) [15,16]. In the heart,
AMP-activated kinase (AMPK) indirectly promotes glycogen storage
by increasing glucose uptake [17] leading to allosteric activation of gly-
cogen synthase via glucose-6-phosphate. Unlike insulin signalling,
AMPK promotes autophagy via activation of ULK1/2 [18] thus providing
a mechanism by which glycogen storage and autophagy may be simul-
taneously regulated. We have previously identiﬁed a role for macro-
autophagic induction in the insulin resistant heart [19–21] and further
work is now required to establish the mechanisms involved in cardiac
metabolic stress-related autophagy. Delineating the macro-autophagic
and glycogen-autophagic response to an acute metabolic challenge in
male and female myocardium may provide mechanistic insight into
the sex-speciﬁc characteristics of cardiac stress responses.
Given that women appear to be more susceptible to metabolic
stress-related cardiac pathology, and that oestrogen upregulates signal-
ling intermediates involved in promotion of glycogen storage (and
potentially glycogen autophagy), we hypothesised that the myocardial
glycogen handling response to metabolic stress would be accentuated
in female myocardium. An acute, experimental pathophysiologic
metabolic challenge was employed to interrogate the sex-speciﬁc char-
acteristics of glycogen-related storage and breakdown processes. Male
and female mice were subjected to 48 h fasting and cardiac glycogen
content, particle size, regulatory enzymes, signalling intermediates
and autophagic processes were evaluated.We demonstrate that female
hearts contain less glycogen than male hearts under basal conditions.
Fasting selectively induced a marked accumulation of glycogen linked
with a decrease in average glycogen particle size in female hearts.
Upregulation of Akt and AMPK signalling and induction of macro- and
glycogen-autophagy is implicated. This study provides the ﬁrst demon-
stration that glycogen autophagy is operational in the heart and reports
the novel ﬁnding that glycogen management in female hearts is espe-
cially responsive to metabolic stress. Our ﬁndings indicate that sex-
speciﬁc differences in glycogen handling may have cardiopathologic
consequences in various settings, including diabetic cardiomyopathy.
2. Materials and methods
2.1. Animals and dietary treatments
C57Bl/6J male and female mice were purchased from the Animal
Resources Centre, Western Australia and were acclimatised within the
University of Melbourne Animal Facility for 1 week in temperature-
controlled conditions in a 12 h light/dark cycle, and were cared for inaccordance with the ‘Principles of laboratory animal care’ (NIH publica-
tion no. 85-23, revised 1985; http://grants1.nih.gov/grants/olaw/
references/phspol.htm) and the National Health and Medical Research
Council of Australia Code of Practice for the Care and Use of Animals
for Scientiﬁc Purposes, and procedures were approved by the Animal
Ethics Committee of the University of Melbourne. A speciﬁc low-soy
dietwas chosen tominimise the impact of phytoestrogens on study out-
comes (Barastoc, Agriproducts, Australia). At 8 weeks of age, micewere
fasted for 48 h, a time point that has been previously established to in-
duce metabolic stress involving upregulation of macro-autophagy [22].
Equal numbers of At the 48 h time point, mice were anaesthetised
(sodium pentobarbital, 70 mg/kg i.p.), hearts excised, rinsed in
HEPES-Krebs buffer, blotted and weighed for determination of cardiac
weight index and snap frozen for molecular analysis. Tibia length was
measured and blood glucose concentrations determined (ACCU-
CHEK® Advantage glucometer). Equal numbers of mice from all groups
were assessed in parallel and all heart tissue was collected between
3 pm and 5 pm. Cardiac dimensions were also determined echo-
cardiographically (see Supplement for details).
2.2. Western blot analysis of myocardial protein expression
Frozen ventricular tissue was homogenised and protein expression
was analysed by western blot as previously described [23]. Brieﬂy, tis-
sue was homogenised in Tris–HCl 100 mM, EGTA 5 mM, EDTA 5 mM
(Sigma Aldrich, MO, USA) buffer containing protease and phosphatase
inhibitors (Roche, Basel, Switzerland). Heart homogenates were stored
in sample buffer (50 mM Tris–HCl, 2% SDS, 0.1% bromophenol blue,
10% glycerol, 2.5% 2-mercaptoethanol). Sample protein concentration
was determined by a modiﬁed Lowry assay [24] and equal amounts of
protein were loaded into the SDS-PAGE gel. Antibodies for pAMPK
(Thr172; Cell Signalling #2535), AMPK (Cell Signalling #2532), pAkt
(Ser473; Cell Signalling #9271), Akt (Cell Signalling #9272), glycogen
synthase (GS; Cell Signalling #3893), pGS (Ser641; Epitomics #1919-
1), glycogen phosphorylase [25], glycogen branching enzyme (GBE;
[26]), glycogen debranching enzyme (GDE; [25]), light chain protein
3B (LC3B; Cell Signalling #2775), p62 (American Research Products
#03-GP62-C), STBD1 [27] and GABARAPL1 (Protein Tech #11010-1-
AP) were utilised to assess protein expression in crude homogenate
samples. Protein expression was determined by SDS-PAGE andwestern
blotting. Equal protein loading was conﬁrmed by staining the PVDF
membranes with Coomassie dye (Coomassie Brilliant Blue R-250;
Biorad, CA, USA).
Phospho-glycogen phosphorylase (pGP (Ser14)) polyclonal anti-
bodies were raised in rabbits against the peptide CKRKQISPO4VRGLA-
amine (GP (9-21) C9 phospho-S14) and afﬁnity puriﬁed through the
dephosphorylated peptide ﬁrst to remove antibodies recognising epi-
topes to the GP peptide itself, followed by the phosphorylated peptide.
Both peptides were immobilised on Sulfolink gel (Pierce, Rockford, IL,
USA). Bound GP phospho-speciﬁc antibodies were eluted with
200 mMglycine pH 3 into aliquots of 100 mMTRIS pH 8 to immediate-
ly adjust the pH and dialysed overnight at 4 °C against 4 L PBS.
Membranes were incubated with anti-rabbit HRP-conjugated sec-
ondary antibody (GE Healthcare UK Ltd., Buckinghamshire, UK). The
ECL Plus (Amersham™, GE Healthcare UK Ltd., Buckinghamshire, UK)
chemiluminescent signal was imaged and analysed using Quantity
One software (Biorad, CA, USA).
2.3. Glycogen assay
Cardiac glycogen concentration was measured by digesting an
aliquot of mouse ventricular crude homogenate with amyloglucosidase
(Sigma-Aldrich, St. Louis, MO, USA) at 50 °C for 20mins in a buffer
containing 0.1 M sodium acetate pH 6.0. Following centrifugation at
14,000 g for 2mins, an aliquotwas removed and glucose levelswere de-
termined using a two enzyme, colorimetric glucose assay (Sigma-
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glucose units (nmol), normalised to protein (mg, determined by Modi-
ﬁed Lowry Assay [24]) and depicted as relative levels for comparative
purposes.
2.4. Periodic Acid-Schiff (PAS) Staining
Heart mid-sections were ﬁxed in 10% formalin (Sigma-Aldrich,
St. Louis, MO, USA) for 24 h, washed with phosphate-buffered saline
and stored in 70% ethanol at 4 °C. Tissue segmentswere then embedded
in parafﬁn and cut into 4 μm sections. Following dewaxing, sections
were oxidised with 1% periodic acid for 5 min, washed and incubated
in Schiff's reagent for 10 min at room temperature. Sections were then
washed and counterstained with Mayer's haematoxylin for 30 s,
washed, dehydrated and mounted in DPX. Selected sections were incu-
bated with 5 mg/ml α-amylase for 5 min at 37 °C (Sigma-Aldrich, MO,
USA) to conﬁrm distinct glycogen and glycoprotein stain localisation.
Images were acquired using a Zeiss Imager DI microscope with a Zeiss
AxioCam MRc5 colour camera (Carl Zeiss, Oberkochen, Germany).
Image analysis was performed using Image Pro Plus (V4.5.1, Media
Cybernetics, MD, USA).
2.5. Glycogen puriﬁcation
Ventricular tissue was homogenised in glycogen isolation buffer (in
mM: 50 HEPES, 150 NaCl, 2 EDTA, protease inhibitor tablet (complete
EDTA-free, Roche Cat#04693132001) and phosphatase inhibitor tablet
(PhosSTOP, Roche Cat#04906837001), pH 7.4) and centrifuged at
7000 g for 10mins at 4 °C. The supernatant was collected, pellet resus-
pended in glycogen isolation buffer and centrifugation repeated. The
resulting supernatant was pooled with the supernatant from the ﬁrst
spin and the sample was subsequently centrifuged at 150,000 g for
45 min at 4 °C. The membrane/glycogen rich pellet was resuspended
in glycogen isolation buffer and homogenised at low speed. The sample
was then layered over a sucrose density gradient (75, 50, 25% (w/v) in
glycogen isolation buffer) and centrifuged at 300,000 g for 120mins at
4 °C. The glycogen fraction pelleted through all three layers whilst
microsomal/membranes were retained within the 25–50% sucrose frac-
tion. To assure glycogen purity, the pellet was resuspended in 50 mM
HEPES, pH 7.5, layered over 200 μl, 75% sucrose in glycogen isolation
buffer and centrifuged at 300,000 g for 30 min at 4 °C. The resultingpel-
let was resuspended in 50 mM HEPES, pH 7.5 and frozen at −80 °C
until required.
2.6. Transmission electron microscopy
Cardiac glycogen was prepared for TEM as previously described for
rat liver and human skeletal muscle glycogen [25] and diluted 1 in 40
initially to determine the appropriate concentration that provided an
even distribution of glycogen particles. Following this, glycogen parti-
cles were examined using a Tecnai 12 Transmission ElectronTable 1
Systemic and cardiac morphological characteristics of control & fasted, male & female mice (48
Control
Male Fem
Body weight (BW, g) 27.2 ± 0.6 19
BW change over treatment period
(% change relative to initial)
1.3 ± 0.9 −0
Heart weight (HW, mg) 141 ± 3 10
Tibia length (TL, mm) 17.6 ± 0.4 16
HW:TL (mg/mm) 8.00 ± 0.12 5.9
Blood glucose (mM) 10.3 ± 0.8 10
Data presented as mean ± s.e.m, n = 5–6/group, 2-way ANOVA, LSD post-hoc tests.
⁎ p b 0.05 vs. respective control.
# p b 0.05 vs. respective male.Microscope (FEI, Eindhoven, The Netherlands) at an operating voltage
of 120 KV as previously described [28]. Images were recorded using a
Megaview III CCD camera and AnalySIS camera software (Olympus) at
a magniﬁcation between 30,000 and 150,000 times. Analysis of the
glycogen particle size (particle diameter) was performed using ImageJ
software as previously described [28].
2.7. Statistical analyses
Data are presented as mean ± standard error of the mean (s.e.m).
Statistical analyses were performed using SPSS v20 (SPSS Inc., IL,
USA). Data were analysed by two-way analysis of variance (ANOVA)
with post-hoc Fisher's LSD tests where appropriate. As required, data
were log10-transformed to achieve a normal distribution. Non-
parametric testing (MannWhitney U) was used when normal distribu-
tion could not be achieved by data transformation. A p-value b0.05was
considered statistically signiﬁcant. Figure statistical annotation (*) spec-
iﬁes post-hoc analysis outcomes. For instanceswhere the 2-wayANOVA
revealed a signiﬁcant overall ‘factor’ effect in the absence of signiﬁcant
post-hoc individual group comparisons, this information is included in
the text, in the ﬁgure legends, and annotated on each panel (†).
3. Results
3.1. Systemic and cardiac morphological characteristics of male and female
fasted mice
After 48 h of fasting, extent of bodyweight reduction was greater in
male than in female mice (22% vs. 16% decrease, relative to pre-fasting
weight, respectively; p b 0.05 fasted male vs. fasted female, Table 1).
Fasting-induced ~61% and ~67% decrease in blood glucose levels in
males and females respectively (p b 0.05 fasted vs. control). Male and
femalemice exhibited similar fasting-induced reduction in heartweight
(~10–13% decrease; p b 0.05 fasted vs. control) and cardiac weight
index (heart weight normalised to tibia length, (~10–12% decrease;
p b 0.05 fasted vs. control, Table 1). Echocardiographic assessment of
a subset of animals revealed a fasting associated reduction in ventricular
wall dimensions (LVIDd; p b 0.05 fasted vs. control) with no indication
of a sex differential in the response (see Supplement Fig. S2). Thus, al-
though somatic weight decrease in response to fasting was modestly
higher in male mice, systemic glycemic and cardiac weight parameters
were not different.
3.2. Sex-speciﬁc effects of fasting on cardiac glycogen content
and regulation
Cardiac glycogen content and regulationwere evaluated inmale and
female mice under control (fed) conditions and subjected to 48 h
fasting. In the control state, the glycogen content of female myocardial
tissues was substantially and signiﬁcantly lower compared with male
(~50% lower; p b 0.05 control male vs. control female; Fig. 1a). Thish treatment period).
Fasted
ale Male Female
.9 ± 0.3# 20.9 ± 0.3⁎ 15.9 ± 0.2⁎,#
.9 ± 0.6 −21.6 ± 1.0⁎ −16.2 ± 0.5⁎,#
1 ± 3# 127 ± 4⁎ 87.6 ± 1⁎,#
.8 ± 0.2# 17.8 ± 0.1 16.7 ± 0.1#
9 ± 0.16# 7.17 ± 0.26⁎ 5.26 ± 0.041⁎,#
.3 ± 1.7 4.0 ± 0.7⁎ 3.4 ± 0.2⁎
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Fig. 1. Effect of 48 h fasting on glycogen handling proteins inmale and female mouse cardiac tissue. (A) Total cardiac glycogen content. (B) Ratio of phosphorylated (Ser641) to total gly-
cogen synthase (GS). See supplementary Fig. S1A& B for representative blots. (C) Ratio of phosphorylated (Ser14) to total glycogenphosphorylase (GP). See supplementary Fig. S1C&D for
representative blots. (D) PAS-glycogen stained (pink) parafﬁn-embedded formalin-ﬁxed ventricular sections. Relative glycogen levels evaluated by image segmentation analysis (arbitrary
pixels/ﬁeld: control male (326,432 arb. pixel units), control female (215,483 arb. pixel units), fasted male (375,630 arb. pixel units), fasted female (416,108 arb. pixel units). (E) PAS-
stained, amylase digested sample section from fasted femalemouse heart (cell glycogen enzymatically removed by amylase, leaving residual extracellular glycoprotein traces, conﬁrming
that PAS stain evident in panel D represents intracellular sites of digestible glycogen deposits). Panel A, B, C: data presented asmean ± s.e.m, n = 6, analysed by 2-wayANOVA, annotated
with LSD post-hoc tests, *(p b 0.05).
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~2.9-fold increase in phosphorylated-GS: total GS ratio; p b 0.05 control
male vs. control female; Fig. 1b) and a higher level of active glycogen
phosphorylase (GP; ~5.2-fold increase in phosphorylated-GP: total GP
ratio; p b 0.05 control male vs. control female; Fig. 1c) relative to male
mouse hearts. In response to fasting, female hearts exhibited a marked
elevation of glycogen (~135% increase; p b 0.05 fasted female vs.
control female) associated with activation of glycogen synthase (~95%
reduction in phosphorylated-GS: total GS ratio; p b 0.05 fasted female
vs. control female; Fig. 1b) and inactivation of glycogen phosphorylase
(~78% reduction in phosphorylated-GP: total GP ratio; p b 0.05 fasted
female vs. control female, Fig. 1c). In contrast, male hearts exhibited
no changes in cardiac glycogen content, glycogen synthase, or glycogen
phosphorylase in response to 48 h fasting. To visualize the cellular local-
ization of glycogen deposits, tissue PAS stainingwas evaluated (Fig. 1d).
This staining was notably prominent in the fasted female myocardial
sections (Fig. 1d, lower right panel). Sectionswere also treatedwith am-
ylase to conﬁrm intracellular site of glycogen occurrence. After amylase
digestion, only residual extracellular glycoprotein staining was evident
(Fig. 1e, sample section).
Thus, in female hearts, it appeared that lower glycogen synthesis
combined with higher glycogen degradation was associated with
lower basal (control) glycogen content relative to males. Fasting
induced a female-speciﬁc activation of glycogen synthesis and inactiva-
tion of glycogen degradation coincident with accumulation of glycogen
stores in females only.
To determine whether glycogen accumulation in fasted female
hearts was associated with alteration in glycogen structure, cardiac gly-
cogen particles were puriﬁed and their diameters determined by trans-
mission electron microscopy. Mean cardiac glycogen particle size was
~11% greater in control females than control males (p b 0.05; Fig. 2a),
and fasting induced a ~15% decrease in mean particle size in femalemice (p b 0.05 fasted female vs. control females). Mean glycogen parti-
cle size in fasted females was ~4% smaller than that in fasted males
(p b 0.05 fasted female vs. fasted male; Fig. 2a). Based on size, glycogen
particles can be characterised as small β particles (b40 nm), or as larger
αparticles (N40 nm), the latter particle type considered to comprise ag-
gregated β particles [25]. The data appearing in Fig. 2a are depicted in
Fig. 2b, to provide alternative visual representation, emphasizing the
relative increase in the proportion of β-particles (i.e. b40 nm) in fasted
females only (compared non-fasted controls). In males, fasting did not
modify either mean particle size or the proportion of particle types.
Fig. 2C provides representative electron micrographs depicting the par-
ticle size distribution in each group.
To assess how the disparate sex effects of fasting on cardiac glyco-
gen content and structure could reﬂect underlying differences in
enzymatically-regulated structural shaping of glycogen (extension and
degradation), expression levels of glycogen branching and debranching
enzymes (GBE and GDE respectively) were evaluated. In control mice,
cardiac GBE expression was ~4.1-fold higher in females compared
with males (p b 0.05, Fig. 3a) consistent with larger average particle
size seen in females. Cardiac GBE expression in fasted female mice
was not statistically different to fastedmalemice. Malemice did not ex-
hibit changes in GBE expressionwith fasting, consistent with the lack of
change in glycogen content and glycogen particle size. GDE expression
was higher overall in females than males (p(sex) b 0.05, 2-way
ANOVA factor effect; Fig. 3b), but was not modiﬁed by fasting for either
sex.
3.3. Sex-speciﬁc signalling mechanisms underlying the fasting-induced
cardiac glycogen response
Glycogen formation and degradation is regulated by amyriad of sig-
nalling pathways involving PI3K/Akt and AMPK signalling, most well
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tive electron microscopy images of glycogen particles depicting the differences in particle
size in male and female control and fasted mouse hearts. All panels: data presented as
mean ± s.e.m, n = 6, analysed by 2-way ANOVA, annotated with LSD post-hoc tests,
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pathway relieves GSK3β inhibition of glycogen synthase. To determine
the role of Akt signalling inmediating the sex-speciﬁc alterations of car-
diac glycogen content with fasting, the total Akt expression and level of
phosphorylation (pAkt) was examined. In control mice, pAkt was ~2.2-
fold higher in females than males (p b 0.05 control male vs. control fe-
male; Fig. 4a). With fasting, in females there was a 2-fold increase in
pAkt (p b 0.05 fasted female vs. control female). Fasted females exhib-
ited ~142% higher pAkt level than fasted males (p b 0.05 fasted female0.0
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Fig. 3. Effect of 48 h fasting on glycogen particle regulatory proteins in male and female
mouse cardiac tissue. (A) Glycogen branching enzyme protein expression. (B) Glycogen
debranching enzyme protein expression, †(p b 0.05) overall sex factor effect. All panels:
data presented as mean ± s.e.m, n = 6, analysed by 2-way ANOVA, annotated with LSD
post-hoc tests, *(p b 0.05).vs. fasted male; Fig. 4a). Total Akt was overall higher in females than
males (control female vs. control male p b 0.05, fasted female vs. fasted
male p b 0.05), and not modiﬁed by fasting (Fig. 4b). The ratio of phos-
phorylated Akt to total Akt was increased by ~89% with fasting in
females (p b 0.05 fasted female vs. control female) whereas the ob-
served trend for increased pAkt:Akt in fasted males (vs. control males)
did not reach statistical signiﬁcance (Fig. 4c). Control males and females
exhibited similar pAkt:Akt expression ratio (Fig. 4c). These data are
consistent with female-speciﬁc stimulation of glycogen synthesis by
fasting-induced Akt activation.
Activation of AMPK signalling can promote glycogen formation by
increasing glucose-6-phosphate, an allosteric activator of glycogen syn-
thase [17]. The sex-dependent role of AMPK signalling in cardiac glyco-
gen handling was evaluated. Myocardial AMPK phosphorylation levels
were similar for control, non-fasted male and female mice (Fig. 4d).
With fasting, females but not males, exhibited increased pAMPK levels
(~39%, p b 0.05 fasted female vs. control female). Thus pAMPK levels
tended to be higher in fasted females relative to fasted males (~33%,
p = 0.052; Fig. 4d). Females exhibited ~47% higher total AMPK expres-
sion than males under control conditions (p b 0.05 control male vs.
control female; Fig. 4e).Males and females exhibited a similar reduction
in total AMPK expressionwith fasting (~19% and ~25% decrease respec-
tively, p b 0.05 fasted vs. control). Fasted females exhibited ~36% higher
total AMPK than fasted males (p b 0.05 fasted female vs. fasted male;
Fig. 4e). The ratio of pAMPK to AMPKwas lower in control females com-
pared to control males (~35%, p b 0.05 control male vs. control female;
Fig. 4f), and increased robustly by ~89% in fasted females (p b 0.05
fasted female vs. control female). Males did not exhibit changes in
pAMPK:AMPK ratio with fasting (Fig. 4f). Thus, lower basal AMPK activ-
ity may underlie lower basal cardiac glycogen content observed in con-
trol females. In fasting, accumulation of cardiac glycogen may involve a
dual activation of glycogen synthase by Akt (via relieving GSK3β inhibi-
tion) and AMPK (via increasing G6P). These data support a female-
selective role for AMPK regulation of cardiac glycogen content under
fasting-induced metabolic stress conditions.3.4. Differential glycogen- and macro-autophagy signalling in male and
female hearts
Recent evidence suggests that glycogen content is regulated by a
speciﬁc ‘glycogen autophagy’ pathway, acting to degrade glycogen
particles for release of free glucose [11,12]. To establish that glycogen
autophagy proceeds in heart tissue, and to determine whether sex
differences in glycogen storage may be associated with autophagic ad-
aptations in fasting, speciﬁc glycogen autophagymarkers were assessed
in ventricular homogenate samples. STBD1 has been identiﬁed to tether
glycogen to the autophagosome via binding to the cognate protein
GABARAPL1 [12]. Indeed, expression of both STBD1 and GABARAPL1
was evident in myocardial tissue. Under control conditions cardiac
STBD1 expression was found to be signiﬁcantly lower in females com-
pared with males (~63% reduction, p b 0.05 control male vs. control fe-
male; Fig. 5a). In response to fasting, female STBD1 levels were elevated
signiﬁcantly (~69% increase, p b 0.05 fasted female vs. control females),
whilst in contrast fasted male STBD1 protein expression was unaltered.
In fasted state, STBD1 expression remained lower in females thanmales,
but the differential was apparently lessmarked anddid not reach signif-
icance (p = 0.088 fasted female vs. fasted male). GABARAPL1 expres-
sion was higher in control females relative to males (p b 0.05 Fig. 5b).
With fasting, GABARAPL1 was signiﬁcantly increased in both males
(~73%, p b 0.05 fasted vs. control) and females (~55%, p b 0.05 fasted
vs. control; Fig. 5b). Thus a disconnection between STBD1 and
GABARAPL1 was apparent. Female myocardial expression of STBD1
was lower, yet GABARAPL1 levels were higher than male. With fasting,
STBD1 and GABARAPL1 increased in parallel in females, but in males,
only GABARAPL1 increased.
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72 M.E. Reichelt et al. / Journal of Molecular and Cellular Cardiology 65 (2013) 67–75To distinguish fasting-induced macro-autophagy and glycogen au-
tophagy responses, markers of macrophagy were evaluated. When elon-
gating the autophagosome membrane, LC3B is transformed into the
phosphatidylethanolamine (PE)-conjugated form (LC3BII). LC3BI is the
inactive, un-conjugated form. The ratio of LC3BII to LC3BI is thus used as
a measure of autophagic activity. p62 is an adaptor molecule which func-
tions to tether proteins and organelles to the autophagosome via binding
to LC3B. A trend towards overall elevated p62 expression in females rela-
tive to males was observed (p(sex) = 0.082, 2-way ANOVA factor effect;
Fig. 6a). In both sexes, fasting signiﬁcantly increased p62 levels (control
male vs. fasted male p b 0.05, control female vs. fasted female p b 0.05).0.0
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73M.E. Reichelt et al. / Journal of Molecular and Cellular Cardiology 65 (2013) 67–75In females, LC3BI (inactive) was ~3.4-fold higher than in males
under control conditions (p b 0.05 control female vs. control male),
and fasting induced a ~77% reduction in expression (p b 0.05 fasted
female vs. control female; Fig. 6c). In males, no effect of fasting on
LC3BI was evident. No difference in LC3BI between fasted males and fe-
males was observed. Fasting induced very marked increases in LC3BII
(active) in bothmales and females (~9.4 fold and ~3.5 fold respectively,
p b 0.05 fasted vs. control; Fig. 6d). LC3BII expression was similar for
males and females. The ratio of active:inactive LC3B (LC3BII:I) was
~57% lower in females relative to males under control conditions
(p b 0.05; Fig. 6b) and was increased ~17-fold by fasting in females
(p b 0.05 fasted female vs. control female), and ~9.8-fold in males
(p b 0.05 fasted male vs. control male; Fig. 6b). Fasted female LC3BII:I
ratio levels were not statistically distinguishable from fasted males.
4. Discussion
To our knowledge, this study provides the ﬁrst evidence that meta-
bolic stress induces a female-speciﬁc cardiac glycogen response. This
study demonstrates that glycogen autophagy (‘glycophagy’) is opera-
tional in adult hearts and presents the novel ﬁnding that glycogen
autophagy is modulated by a pathophysiologic stimulus (fasting) in a
sex-speciﬁc manner. Basally, females exhibit lower cardiac glycogen
content thanmales,which is stored in the formof larger average particle
size. With fasting, glycogen accumulation in female hearts is evident,
driven by Akt and AMPK signalling activation, and associated with
upregulation of glycogen autophagy proteins STBD1 and GABARAPL1.
These ﬁndings suggest that female hearts operate with lower glycogen
stores under basal conditions and have a selective capacity to switch
on a glycogen response in a setting of metabolic stress — a response
which is potentially maladaptive.
4.1. Cardiac glycogen accumulation is female-speciﬁc
The occurrence of cardiac glycogen accumulation in human diabetic
patients and experimental animal diabetic models has been known for
some time (i.e. more than 60 years) [5–7,29], yet surprisingly, the
processes of glycogen turnover in the heart have received only modest
attention. Clinical studies have reported that diabetic females have a
higher risk of cardiac complications than diabetic males [2]. Sex differ-
ences in cardiac glycogen handling have not been previously investigat-
ed. In the present study, as a ﬁrst step towards understanding the basis
for glycogen mis-handling in energy stress, we employed a non-patho-
logicalmetabolic challenge (fasting) to evaluate the fundamental differ-
ences in glycogen-related storage and access responses in male and
female hearts. Cardiac glycogen was lower in females compared to
males under control conditions, coincident with lower glycogen syn-
thase activity and higher glycogen phosphorylase activity. Branching
enzyme expression was markedly higher (~4.1 fold) in control female
hearts relative to males and associated with larger average particle
size. Thus, although overall cardiac glycogen content was lower in
control females, the glycogen particles are apparently more branched
and exist in the form of aggregate α particles. In response to fasting,
females, but not males, increased glycogen synthase activity and re-
duced glycogen phosphorylase activity resulting in increased cardiac
glycogen content. Interestingly, the accumulation of glycogen in females
was coincident with a reduction in average particle size suggesting that
new glycogen is formed as smaller β particles. Sex differences in cardiac
glycogen content in fasted mice were not linked to differential fasting-
induced cardiac atrophy (a similar cardiac weight index reduction was
observed in males and females, 10–12% decrease, Table 1; consistent
with previous reports [30,31]). Earlier reports of cardiac glycogen levels
in hearts of male fasted rodents have been inconsistent (unchanged,
decreased, elevated levels observed) [32–35]. In female rats, no change
in cardiac glycogen with fasting has been previously observed [32],
however the use of a soy-based protein diet (known to containrelatively high phytoestrogen content) in this previous study may
have inﬂuenced the sex differences observed. A 48 h fasting interven-
tion appearsmore severe inmice than in rats, inducing ~62–68% reduc-
tion in blood glucose levels in mice (present study) vs. only 10%
reduction [33], ~30% reduction [32] or no change [35] in blood glucose
levels in rats, thus direct comparison of fasting studies in different
species is difﬁcult. It is possible that in the present study involving
mice, the 48 h fast was optimal for discriminating the sexually dimor-
phic response, and that with prolonged energy stress, a male glycogen
storage response may become apparent. It may be important that the
signiﬁcant sex differences in the energy stress response involving glyco-
gen handling are evident in a setting where phytoestrogen dietary
constituents aremaintained at a low level (as in the present study utiliz-
ing a low-soy diet). Glycogen content was evaluated in crude heart ho-
mogenate samples. Whether fasting induces myocardial regional- or
epi-/endo-cardial-speciﬁc changes in glycogen content is yet to be
determined. To date, oestrogen response elements in the genes which
encode the enzymes involved in glycogen regulation have not been re-
ported (glycogen synthase (GYS1), glycogen phosphorylase (PYGM),
glycogen branching enzyme 19 (GBE1) or glycogen debranching en-
zyme (AGL) [36]. Given that the expression proﬁles of glycogen regula-
tory proteins were remarkably different in male and female hearts in
the present study, a detailed investigation into the inﬂuence of sex ste-
roids on the expression of glycogen regulatory genes is nowwarranted.
Interestingly, cardiac glycogen accumulation is reported in females dur-
ing pregnancy [37]. Thus a female-speciﬁc evolutionary adaptationmay
underlie the observation in the present study that females, but not
males, have the capacity to increase cardiac glycogen stores in response
to metabolic stress.
4.2. Sex-dependent induction of glycogen handling signalling with fasting
The PI3K/Akt signalling pathway is known to promote glucose stor-
age via relieving GSK3β inhibition of glycogen synthase. Expression of
Akt is modulated by oestrogen and consistently reported to be higher
in female hearts [3,38–40]. Indeed phosphorylated and total Akt is
higher in female hearts under basal conditions in the present study.
Given that Akt phosphorylation of GSK3β leads to activation of glycogen
synthase, higher Akt expression in females might be expected to pro-
mote higher levels of cardiac glycogen in females. But surprisingly,
female mice exhibited less cardiac glycogen content than males under
basal conditions. Thus, glycogen downregulation in female hearts may
be driven by a different signalling pathway. More recently, AMPK sig-
nalling has been shown to increase G6P-allosteric activation of glycogen
synthase in the heart and in skeletal muscle by increasing glucose
uptake [17,41]. In the present study, lower AMPK signalling drive (as
evidenced by lower pAMPK(Thr172):AMPKα ratio, Fig. 4f)may provide
a mechanism by which cardiac glycogen content is maintained at a
lower basal level in female hearts compared with male hearts. With
fasting, both Akt and AMPK signalling pathways are activated in females
coincident with marked accumulation of glycogen. Given that plasma
insulin levels are decreased with fasting [8,42–44], the mechanism of
fasting-induced activation of the PI3K/Akt ‘insulin’ signalling pathway
in females is likely to be ligand-independent and may involve intracel-
lular modulation of signalling intermediates. Further investigation is re-
quired to establish the mechanism of female-speciﬁc Akt response to
metabolic stress.
In some settings of acutemetabolic stress, cardiac glycogen accumu-
lation appears to be an adaptive response. Male mice overexpressing
AMPKγ exhibited improved post-ischemic outcomes relative to
wildtypes. This protection was abrogated when glycogen stores were
depleted prior to the ischemic insult [45]. In other settings however, ev-
idence suggests that glycogen accumulation is maladaptive. Constitu-
tive activation of the γ2 regulatory subunit of AMPK in humans
(arising due to a mutation of the PRKAG2 gene) resulted in accumula-
tion of glycogen-ﬁlled vesicles and hypertrophic cardiomyopathy [46].
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opathy, glycogen accumulation has been shown to occur in association
with a derangement of myoﬁbrillar and cytoskeletal proteins [47,48].
Pompe disease is characterised by a progressive skeletal and cardiac
pathology in association with glycogen accumulation. X-ray diffraction
studies have linked this glycogen deposition with reduced interaction
between actin andmyosin [49]. The cardiac phenotype of glycogen stor-
age diseases, such as Pompe's disease, supports the contention that
excess glycogen storage plays a causal role in cardiac dysfunction.
Whether excess glycogen storage directly mediates contractile abnor-
malities in other pathological settings is yet to be established. The ﬁnd-
ings from the present study suggest that cardiac glycogen handling is
distinctive, and there is a sex speciﬁcity to the regulatory processes
which may confer cardiopathology vulnerability.
4.3. Sex-speciﬁcity of distinct macro- and glycogen-autophagic pathways
Cellular glycogen exists in both the cytosol and in vacuolar/
autophagosomal bodies [50]. Cytosolic glycogen is broken down by
the combined actions of glycogen phosphorylase and glycogen
debranching enzyme. Lysosomally-derived glycogen-hydrolyzing acid
α-glucosidase (GAA) is required for autophagosomal glycogen degrada-
tion [50]. Pompe disease, caused by deﬁciency in (GAA), impacts most
severely on cardiac and skeletal muscle tissue [51] underscoring the
importance of glycogen autophagy in these organs. In a similar manner
to the p62 tagging of ubiquinated proteins to LC3B [52], STBD1 binds
glycogen and anchors it to pre-autophagosome membranes by binding
to GABARAPL1 [13], a protein which was originally isolated from endo-
metrial cells and identiﬁed through its transcriptional induction by
oestrogen [14]. Indeed, consistent with this estrogenic link, in the pres-
ent studywe ﬁnd that GABARAPL1 expression is higher in female hearts
relative to male hearts (Fig. 5b). Under basal conditions female hearts
exhibit markedly lower STBD1 expression than males, contrasting
with the GABARAPL1 ﬁndings. Very little is known about the relation-
ship between GABARAPL1 and STBD1 expression regulation, and our
ﬁndings provide new insights. Female hearts may exhibit a ‘reserve’ ca-
pacity for glycogen autophagy via GABARAPL1, whereas STBD1 expres-
sion levels follow the shift in intracellular content of its ‘ligand’ —
glycogen. Given that fasting increases glycogen content in female
hearts, it is surprising that the glycogen autophagic degradation route
is also increased. It would appear that in fasted female hearts, even
though glycogen autophagic degradation is upregulated, elevation of
the glycogen content is still observed. This suggests that induction of
glycogen autophagy is secondary to glycogen accumulation in female
fasted hearts.
This study provides a simultaneous evaluation of macro-autophagy
and glycogen autophagy markers in cardiac tissue. The importance of
macrophagy (often referred to more generally as ‘autophagy’) as a pro-
cess involving primarily bulk phagic degradation of protein macromol-
ecules is increasingly recognised andmore pronounced susceptibility to
autophagy induction in females has been reported in non-cardiac cell
types [53,54]. We demonstrate that female hearts exhibit an enhanced
‘reserve’ for LC3B induction (i.e. higher basal levels of ‘inactive’ LC3B-I)
but interestingly, fasting activated LC3B similarly in males and females,
at least at the 48 h timepoint. A trend for increased p62 expression was
observed in female hearts (p = 0.082) and p62 increased with fasting
similarly in both sexes (Fig. 6a). STBD1 may be considered to be the
‘glycophagy’ equivalent to p62 (i.e. the adaptor molecule which medi-
ates membrane localisation of phagic target). Intriguingly, there is a
sex-speciﬁcity in the expression response of these molecules. STBD1 is
lower in control females whilst p62 is slightly higher, and fasting
increases STBD1 expression in females only but p62 is induced by
fasting in both sexes). These ﬁndings provide further evidence that
the macro-autophagy and glycogen autophagy pathways are distinct
andmaybe subject to dissimilar regulatory inﬂuence. A novel ﬁeld of in-
vestigation is now apparent — new understanding of the role of sexsteroids (systemic and locally produced) in the co-regulation of
glycophagy and macrophagy is required and experimental approaches
which use selective pharmacologic and genetic interventions to manip-
ulate androgen and oestrogen levels will be informative.
Although little is known about the signalling pathways which regu-
late glycogen autophagy, knowledge of the regulation of macro-
autophagy is further advanced (although is mostly extrapolated from
studies in non-cardiac tissues). PI3K/Akt signalling has been shown to
inhibit macro-autophagy via promoting mTOR inhibition of ULK1/2
[15,16]. In this study, simultaneous upregulation of Akt activity and au-
tophagy markers with fasting is observed, presenting an alternative
mechanistic context. In the fasting context it appears that the autopha-
gic upstream signalling drive is not via Akt but via AMPK activation of
ULK1/2 [55,56] indicating a complex relationship between mTOR and
AMPK signalling actions on autophagic processes.
5. Conclusions
In conclusion, this study provides the ﬁrst evidence that through
regulation of key glycogen handling proteins, female myocardial glyco-
gen store levels are lower thanmales under basal conditions, and female
hearts display a unique glycogen accumulation response to fasting. We
identify paradoxical (insulin-independent) Akt activation in response to
fasting, consistent with increased glycogen in females. Importantly, in
female hearts the anti-autophagic actions of Akt appear to be overrid-
den by AMPK signalling in response to acute energy stress, resulting in
both macrophagy and glycophagy induction. Glycogen autophagy ap-
pears to be an adaptive response in this setting and further work is
now required to establish the speciﬁc role of glycogen autophagy in car-
diac metabolic stress. Our ﬁndings of female-speciﬁc cardiac glycogen
handling response to metabolic stress may have important implications
for cardiac pathologies such as diabetes in which females are identiﬁed
to be at higher risk than males. Further work directed towards under-
standing female speciﬁc glycogen handling dysregulation in such path-
ologic settings is now warranted.
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